Details:
-
Alternative Title:Facts about DES and breast cancer
-
Corporate Authors:
-
Description:DES – a synthetic estrogen that was prescribed to pregnant women during 1938—1971 to prevent miscarriages or premature delivery – has been linked to several health risks. Included among these, is an increased risk of breast cancer among women who were prescribed DES while pregnant and DES Daughters – women who were exposed to DES in the womb.
Research available through CDC’s DES Update currently confirms the following facts pertaining to the affect of DES exposure on a woman’s risk for breast cancer.
Publication date from document properties.
DES&BreastCancerFS.pdf
-
Subjects:
-
Document Type:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: